• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与进展为可转诊视网膜病变相关的风险因素:爱尔兰共和国的 2 型糖尿病队列研究。

Risk factors associated with progression to referable retinopathy: a type 2 diabetes mellitus cohort study in the Republic of Ireland.

机构信息

Wellcome-Wolfson Institute for Experimental Medicine, Belfast, UK.

Centre for Public Health, Queens University, Belfast, UK.

出版信息

Diabet Med. 2020 Jun;37(6):1000-1007. doi: 10.1111/dme.14278. Epub 2020 Mar 17.

DOI:10.1111/dme.14278
PMID:32096253
Abstract

AIM

To determine factors associated with progression to referable diabetic retinopathy in people with type 2 diabetes in the Republic of Ireland.

RESEARCH DESIGN AND METHODS

The study was conducted in a dynamic cohort of 2770 people with type 2 diabetes, recruited between April 2005 and July 2013. Systemic factors (systolic and diastolic blood pressure, HbA , lipid levels, BMI) and baseline diabetic retinopathy grading results were evaluated at 4-monthly and yearly intervals, respectively. Associations between risk factors (most recently recorded value, and rate of change in value between pairs of consecutive systemic evaluations) and development of referable diabetic retinopathy were estimated using Cox proportional hazards models.

RESULTS

There was a fourfold increased risk of progression to referral when retinopathy was present at baseline vs no retinopathy at baseline (hazard ratio 4.02, 95% CI 2.80-5.78; P<0.001). Higher current values of HbA (hazard ratio 1.22, 95% CI 1.11-1.34; P<0.001), systolic blood pressure (hazard ratio 1.29, 95% CI 1.15-1.45; P<0.001) and triglycerides (hazard ratio 1.10, 95% CI 1.03-1.18; P=0.004) were associated with increased risk of referral. Higher current BMI (hazard ratio 0.83, 95% CI 0.73-0.95; P=0.007) and diastolic blood pressure (hazard ratio 0.91, 95% CI 0.85-0.97; P=0.006) were associated with reduced risk of referral.

CONCLUSIONS

Presence of retinopathy at baseline was strongly associated with increased risk of referral. Modest associations between systemic factors and risk of progression to referable retinopathy were detected.

摘要

目的

确定与爱尔兰 2 型糖尿病患者进展为可转诊的糖尿病视网膜病变相关的因素。

研究设计和方法

本研究纳入了 2005 年 4 月至 2013 年 7 月期间招募的 2770 名 2 型糖尿病患者的动态队列。分别在每 4 个月和每年评估系统因素(收缩压和舒张压、HbA1c、血脂水平、BMI)和基线糖尿病视网膜病变分级结果。使用 Cox 比例风险模型估计危险因素(最近记录的值以及连续两次系统评估之间值的变化率)与发展为可转诊的糖尿病视网膜病变之间的关联。

结果

与基线时无视网膜病变相比,基线时存在视网膜病变患者进展为转诊的风险增加了四倍(风险比 4.02,95%CI 2.80-5.78;P<0.001)。当前较高的 HbA1c 值(风险比 1.22,95%CI 1.11-1.34;P<0.001)、收缩压(风险比 1.29,95%CI 1.15-1.45;P<0.001)和甘油三酯(风险比 1.10,95%CI 1.03-1.18;P=0.004)与转诊风险增加相关。当前较高的 BMI(风险比 0.83,95%CI 0.73-0.95;P=0.007)和舒张压(风险比 0.91,95%CI 0.85-0.97;P=0.006)与转诊风险降低相关。

结论

基线时存在视网膜病变与转诊风险增加密切相关。检测到系统因素与进展为可转诊的糖尿病视网膜病变风险之间存在适度关联。

相似文献

1
Risk factors associated with progression to referable retinopathy: a type 2 diabetes mellitus cohort study in the Republic of Ireland.与进展为可转诊视网膜病变相关的风险因素:爱尔兰共和国的 2 型糖尿病队列研究。
Diabet Med. 2020 Jun;37(6):1000-1007. doi: 10.1111/dme.14278. Epub 2020 Mar 17.
2
Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland.苏格兰 2 型糖尿病诊断时的糖尿病视网膜病变。
Diabetologia. 2012 Sep;55(9):2335-42. doi: 10.1007/s00125-012-2596-z. Epub 2012 Jun 12.
3
High prevalence in Malawi of sight-threatening retinopathy and visual impairment caused by diabetes: identification of population-specific targets for intervention.马拉维糖尿病导致的威胁视力的视网膜病变和视力损害的高患病率:确定特定人群的干预目标
Diabet Med. 2014 Dec;31(12):1643-50. doi: 10.1111/dme.12492. Epub 2014 Jun 7.
4
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.增生性糖尿病性视网膜病变在糖尿病性视网膜病变患者中发展和进展的预测因素。
Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD013775. doi: 10.1002/14651858.CD013775.pub2.
5
Severity of Diabetic Retinopathy and the Risk of Future Cerebrovascular Disease, Cardiovascular Disease, and All-Cause Mortality.糖尿病视网膜病变的严重程度与未来脑血管疾病、心血管疾病和全因死亡率的风险。
Ophthalmology. 2021 Aug;128(8):1169-1179. doi: 10.1016/j.ophtha.2020.12.019. Epub 2020 Dec 25.
6
Incidence and progression of diabetic retinopathy in Japanese adults with type 2 diabetes: 8 year follow-up study of the Japan Diabetes Complications Study (JDCS).日本 2 型糖尿病患者糖尿病视网膜病变的发病和进展:日本糖尿病并发症研究(JDCS)的 8 年随访研究。
Diabetologia. 2011 Sep;54(9):2288-94. doi: 10.1007/s00125-011-2199-0. Epub 2011 Jun 1.
7
Refractive Error and Retinopathy Outcomes in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.1 型糖尿病的屈光不正与视网膜病变结局:糖尿病控制与并发症试验/糖尿病干预与并发症流行病学研究。
Ophthalmology. 2021 Apr;128(4):554-560. doi: 10.1016/j.ophtha.2020.09.014. Epub 2020 Sep 14.
8
Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis.威尔士糖尿病视网膜病变筛查服务就诊的 2 型糖尿病患者中糖尿病视网膜病变的发生率:回顾性分析。
BMJ. 2012 Feb 22;344:e874. doi: 10.1136/bmj.e874.
9
Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin.与多次皮下胰岛素注射相比,持续皮下胰岛素输注治疗与视网膜病变进展减少相关。
Diabetologia. 2021 Aug;64(8):1725-1736. doi: 10.1007/s00125-021-05456-w. Epub 2021 May 8.
10
Prevalence and risk factors for diabetic retinopathy: the Beijing Communities Diabetes Study 6.糖尿病视网膜病变的患病率及危险因素:北京市社区糖尿病研究 6.
Retina. 2012 Feb;32(2):322-9. doi: 10.1097/IAE.0b013e31821c4252.

引用本文的文献

1
Predicting the need for diabetic macular oedema treatment from photographic screening in the Singapore Integrated Diabetic Retinopathy Programme (SiDRP).在新加坡糖尿病视网膜病变综合项目(SiDRP)中,通过照片筛查预测糖尿病性黄斑水肿治疗需求。
Eye (Lond). 2025 Feb 28. doi: 10.1038/s41433-025-03725-1.
2
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.增生性糖尿病性视网膜病变在糖尿病性视网膜病变患者中发展和进展的预测因素。
Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD013775. doi: 10.1002/14651858.CD013775.pub2.
3
Association of different kinds of obesity with diabetic retinopathy in patients with type 2 diabetes.
不同类型肥胖与 2 型糖尿病患者糖尿病视网膜病变的相关性。
BMJ Open. 2022 May 19;12(5):e056332. doi: 10.1136/bmjopen-2021-056332.
4
The Importance of Close Follow-Up in Patients with Early-Grade Diabetic Retinopathy: A Taiwan Population-Based Study Grading via Deep Learning Model.早期糖尿病视网膜病变患者密切随诊的重要性:基于深度学习模型分级的台湾人群研究。
Int J Environ Res Public Health. 2021 Sep 16;18(18):9768. doi: 10.3390/ijerph18189768.
5
Association between smoking history and optical coherence tomography angiography findings in diabetic patients without diabetic retinopathy.吸烟史与无糖尿病视网膜病变的糖尿病患者光学相干断层扫描血管造影结果的相关性。
PLoS One. 2021 Jul 9;16(7):e0253928. doi: 10.1371/journal.pone.0253928. eCollection 2021.
6
Testing the performance of risk prediction models to determine progression to referable diabetic retinopathy in an Irish type 2 diabetes cohort.测试风险预测模型在爱尔兰 2 型糖尿病队列中预测可转诊糖尿病视网膜病变进展的性能。
Br J Ophthalmol. 2022 Aug;106(8):1051-1056. doi: 10.1136/bjophthalmol-2020-318570. Epub 2021 Apr 26.
7
Genome-wide polygenic risk score for retinopathy of type 2 diabetes.2 型糖尿病视网膜病变的全基因组多基因风险评分。
Hum Mol Genet. 2021 May 29;30(10):952-960. doi: 10.1093/hmg/ddab067.